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Commissioning an Anthropomorphic Spine and Lung Phantom for Remote Dose
Verification of Institutions Participating in RTOG 0631
Publication No.:____________
Douglas F. Caruthers
Supervisory Professor: Geoffrey Ibbott, Ph.D.
The RPC developed a new phantom to ensure comparable and consistent radiation
administration in spinal radiosurgery clinical trials. This study assessed the phantom’s
dosimetric and anatomic utility. The ‘spine phantom’ is a water filled thorax with
anatomy encountered in spinal radiosurgery: target volume, vertebral column, spinal
canal, esophagus, heart, and lungs. The dose to the target volume was measured with
axial and sagittal planes of radiochromic film and thermoluminescent dosimeters (TLD).
The dose distributions were measured with the radiochromic film calibrated to the
absolute dose measured by the TLD. Four irradiations were administered: a four angle
box plan, a seven angle conformal plan, a seven angle IMRT plan, and a nine angle
IMRT plan (denoted as IMRT plan #1 and plan #2, respectively). In each plan, at least
95% of the defined tumor volume received 8 Gy. For each irradiation the planned and
administered dose distributions were registered via pinpricks, and compared using point
dose measurements, dose profiles, isodose distributions, and gamma analyses. Based on
previous experience at the RPC, a gamma analysis was considering passing if greater
than 95% of pixels passed the criteria of 5% dose difference and 3 mm distance-toagreement. Each irradiation showed acceptable agreement in the qualitative assessments
and exceeded the 95% passing rate at the 5% / 3 mm criteria, except IMRT plan #1,
which was determined to have been poorly localized during treatment administration. The
measured and planned dose distributions demonstrated acceptable agreement at the 5% /
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3mm criteria, and the spine phantom was determined to be a useful tool for the remote
assessment of an institution’s treatment planning and dose delivery regimen.
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Chapter 1
1.1

Introduction

Spinal Metastases and Radiation Therapy
The spine is the most common site for bony metastases. An estimated 40% of cancer

patients develop spinal metastases, and approximately 10-20% of these patients suffer
symptomatic spinal cord compression from these lesions. This amounts to more than 25,000
cases per year. Approximately 70% of spinal tumors originate from a primary tumor
elsewhere in the body, the majority from primary cancers of the lung, breast, and prostate.
Lesions can also originate in the spine; these include meningiomas, schwannomas, osseus
tumors, and gliomas. Spinal cord compression often presents with back pain, instability, and
neurologic deficit (Klimo 2004).
Management of spinal tumors includes radiation, surgery, and chemotherapy. The
role of radiation has evolved with developments in diagnostic imaging, inverse treatment
planning, image-guided therapy, and intensity modulated radiation therapy (IMRT). As more
institutions across the country are able to deliver highly conformal doses with smaller
margins of error, hypo-fractionated and single-fraction treatments for spinal tumors show
increasing promise as a new standard of care. This type of approach, when applied to the
head and spine, falls under the banner of ‘sterotactic radiosurgery’ (SRS). This term, coined
by Lars Leksell in the 1950’s, was based on combining an intracranial guidance device and
an orthovoltage X-ray unit. Since then, the term has come to encompass techniques for
delivering a high dose of radiation in a small number of fractions (< 5) with a high degree of
spatial accuracy using image guidance and immobilization (Dodd 2008). In the literature,
spinal radiosurgery is often categorized under SRS or under stereotactic body radiotherapy

(SBRT). In this paper, radiation delivered to spinal tumors in a single fraction with image
guidance and immobilization will be referred to as spinal radiosurgery.
A previous Radiation Therapy Oncology Group (RTOG) trial established that a single
dose of 8 Gy accomplished the same degree of pain relief as 10 fractions of 3 Gy (a total
dose of 30 Gy) (RTOG 2009). However, these results were based on conventional
administration of radiation (non-IMRT). The optimum dose level using ‘dose-painting’
techniques for spinal metastases is actively under investigation (RTOG 2009). Ryu et al.
treated patients with image-guided radiosurgery on a BrainLAB (Westchester, IL) Novalis®
system (treatments were intensity modulated with a micro MLC); these patients received
single fraction doses of 10 to 16 Gy, and achieved an overall pain control rate for one year of
84% (Ryu 2008). Gerszten et al. described the success they had with single fraction dose,
delivered on an Accuray (Sunnyvale, CA) Cyberknife® system (a cylindrically collimated
linac on an articulating robotic arm), from 12.5 to 25 Gy; 290 of their 336 cases achieved
long term pain improvement (Gerszten 2007). Chang et al. treated 74 patients with
metastatic spinal lesions with IMRT and near simultaneous CT guidance; these patients
received 6 Gy in 5 fractions, later amended to 9 Gy in 3 fractions. Chang et al. reported 84%
progression free incidence after 1 year (Chang 2007). These studies described the benefit
achieved at escalated dose levels; however, there has been a dearth of prospective studies on
the benefit of an escalated prescription level. This dearth is being addressed by the Radiation
Therapy Oncology Group (RTOG). The RTOG is currently enrolling patients into protocol
0631, a phase II/III study of image-guided radiosurgery/stereotactic body radiotherapy for
localized spine metastases. This protocol randomizes patients into two arms. The first arm
treats patients with an escalated dose level in a single fraction (16 Gy) delivered via ‘dose-
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painting’ techniques (such as IMRT); the second arm uses a single fraction at a lower dose
level (8 Gy) delivered conventionally (non-IMRT). Both arms of the protocol require image
guidance and immobilization in order to ensure treatment accuracy (RTOG 2009).

1.2

The Radiological Physics Center and Remote Quality Assurance
The Radiological Physics Center’s (RPC) mission is “to assure NCI and the

Cooperative Groups that institutions participating in clinical trials deliver prescribed
radiation doses that are clinically comparable and consistent.”
The RPC accomplishes this mission in several ways: machine output checks with
mailed TLD, dose algorithm checks on reference patients, quality assurance procedure
reviews, on-site dosimetry review visits, credentialing for participation in clinical trials, and
retrospective reviews of an institution’s treatment records. The RPC also utilizes
anthropomorphic phantoms for remote quality assurance. The RPC employs head and neck,
thorax, and pelvic phantoms, among others. Typically, the phantoms are water-filled and
contain materials of different densities in simple geometries to model the anatomy of interest.
Dosimetry is accomplished using film and thermoluminescent dosimeters (TLD) loaded into
the organs-at-risk and the treatment volumes. The phantoms are mailed to institutions
participating in clinical protocols. The institution irradiates the phantom according to their
treatment plan and procedures, and sends the phantom back to the RPC. The RPC then
assesses the delivered dose (measured via the radiochromic film and TLD) to ensure it
conforms both to the prescribed treatment plan and to standards set forth by a given protocol.
This process enables the RPC to verify an institution’s entire treatment process: imaging,
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planning, dose calculation, positioning, and dose delivery, before treatments are administered
to patients.
The RTOG Protocol 0631 falls under the RPC’s purview. The RPC designed a new
phantom to address this new clinical protocol. The materials, anatomical layout and dose
measurement geometry of this new phantom are described more fully in the Methods and
Materials section. Essentially, the new phantom, denoted herein as the ‘spine phantom’, is a
water-filled anthropomorphic chest with low-density lungs and a spine insert that simulates
the spinal cord, vertebral column, esophagus, and target volume.
However, the utility of this newly designed and manufactured spine phantom has to
be verified before it can be used as a dosimetry tool by the RPC. This work tested the utility
of the spine phantom. Both the anatomic utility and dosimetric utility were assessed. The
planning utility concerned how well the spine phantom represented the challenges of
planning spinal irradiations in the layout and proportion of the organs-at-risk and target
volumes. The dosimetric utility concerned whether TLD and radiochromic film recovered
from the phantom consistently measured the administered dose. Establishing the dosimetric
utility was accomplished through the administration of radiation treatment plans of varying
complexity, and assessing how well the results, measured via radiochromic film and TLD,
agreed with the planned dose distribution.

1.3

Dosimeters
The remote dosimetry system utilized by the RPC is a combination of radiochromic

film and thermoluminescent dosimeter (TLD). The radiochromic film used is this project
was Gafchromic EBT film, manufactured by International Specialty Products (Columbia,
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MD). The optical density (OD) of the radiochromic film increases as a function of dose, and
does not require development. The film was used to measure relative dose distributions. The
TLD measured an absolute dose to a small volume, to which the relative dose distribution
was calibrated. The system is discussed in more detail in Methods and Materials section.

1.4

Hypothesis and Specific Aims

Hypothesis:
The newly constructed spine phantom provides a useful model for planning intensity
modulated radiosurgery for spinal tumors, and the collapsed-cone convolution dose
algorithm accurately models the dose distributions measured via radiochromic film and TLD.
This hypothesis was tested by the following specific aims:
Specific Aims:
1. Qualitatively assess the anatomic layout of the spine phantom and how well it
models anatomical features of a patient of similar chest breadth.
2. Develop treatment plans that do not use intensity modulation to irradiate the
treatment volume to the relevant prescription dose.
3. Develop intensity-modulated treatment plans with clinically relevant prescription
dose to the planned tumor volume and clinically relevant dose constraints on the
organs at risk.
4. Compare the planned and measured dose distributions with quantitative and
qualitative assessments: point dose, dose profiles, and isodose distributions.
5. Compare the planned and measured dose distributions using a gamma analysis
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Chapter 2
2.1

Methods and Materials

The Spine Phantom

2.1.1 Schematic and Materials
The spine phantom has overall dimensions of 40 cm width by 30 cm height by 30 cm
length. The outer shell is a 6 mm thick shell of polyvinyl chloride. Inside the shell, a nylon
sphere serves as the heart. The left lung is a removable cylindrical compressed cork insert
with a tumor feature; this phantom also serves as a remote quality assurance tool for lung
protocols. The right lung is permanent, and is also made of compressed cork. A large hole
with a sealing screw cap is located on the superior end of the phantom for water filling. Any
portion of the inner cavity of the shell not occupied by anatomy fills with water; this serves
the dual purpose of near tissue equivalence and provides ease of handling the unfilled
phantom. These features are illustrated in Figure 2.1.
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Density (g/cm3)

Anatomy:

Material

Heart

Nylon

1.06

Tumor

Acrylic

1.07

Spine

Polystyrene

1.2

Spinal Canal

Solid Water

1.03

Lung

Cork

0.3

Figure 2.1: An illustration of the spinal phantom with mid-axial and mid-sagittal views from
CT imaging. The anatomical features are labeled and the materials and densities listed in
the table above.
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Figure 2.2: A schematic of the axial isocenter plane of the spinal insert. The crosses denote
the pin-prick locations used for localization.

The spine insert was designed and built at the RPC based on the anatomy of sample
patients selected as representative cases for spinal radiosurgery. The spinal insert, highlighted
in Figure 2.1, is loaded inferiorly into the spine phantom, and has dimensions of 30 cm by 10
cm by 4 cm. The insert runs the length of the phantom, between the posterior portions of the
lungs. When inserted, the insert locks into place with screws for reproducible placement.
The insert contains pertinent anatomy for spinal irradiations: spinal cord, esophagus,
vertebral column, and a target volume, the anatomical features are shown in Figure 2.2. The
materials chosen for these anatomical features roughly correspond to anatomical densities,
and are detailed in section 3.2. The different materials provide CT contrast for ease of
anatomical contouring.
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2.1.2 Dose Measurement in the Spinal Insert
The spinal insert, when removed, disassembles into a superior and inferior portion,
depicted in the Figure 2.3. The disassembled portions of the spinal insert bisect the acrylic
tumor volume.

Figure 2.3: A photograph of the removed spinal insert. To illustrate the relative location of
the film planes, radiochromic film was placed on the sagittal and axial planes of the
disassembled insert. Also, the different materials used in the construction of the anatomy of
interest are visible.
The radiochromic film was cut exactly to the axial dimensions of the spinal insert.
Three pins are embedded in the axial face of the dissembled spinal insert. When placed onto
the axial plane of the spinal insert, the radiochromic film is pierced by the pins, registering
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the axial film slice to the fixed geometry of the pins. For the sagittal dose plane, slices were
machined into the spine insert, creating a thin sagittal plane bisecting the tumor volume.
Radiochromic film was inserted into these cuts for sagittal dose distribution measurement.
Once inserted, the sagittal film slices can be registered with pinpricks through holes that
traverse the spine insert, perpendicular to the sagittal film plane. The pin-pricks on the film
correspond to the known geometry of the holes for registration.
Figure 2.4 shows the relation of the axial and sagittal film planes in the spine insert
and the relative location of the TLD capsules. The varied spatial position of the TLD
capsules within the target volume provided measurements of absolute dose at various depths.

Figure 2.4: An illustration of the sagittal and axial film slices (the axes of the TLD capsules
run parallel to the sagittal film); each TLD capsule is located within the PTV, and their
locations relative to the target volume center are labeled.
The radiochromic film utilized in this project, Gafchromic EBT, has properties that
make it ideal for use in remote quality assurance applications. The film requires no
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development, and can be cut to any shape required by the dimensions of the film plane. The
film is insensitive to visible light, allowing for ease of use and portability. The radiochromic
film has a high spatial resolution allowing for the measurement of the steep dose gradients
used in spinal radiosurgery. The film can also be calibrated over a clinically useful range of
doses (up to 10 Gy), is water equivalent, and the response is independent of energy and dose
rate. Fuss et al. also found the film response independent of beam quality by irradiating the
film at different depths. This characteristic is particularly useful, as calibration of the film
need not be conducted at the depth at which it is placed in the phantom. The main caveat for
use of Gafchromic EBT film is that it continually develops; thus, it is not well suited to
permanent storage of dose data (Fuss 2007).
The film was cut to the required size and shape for the spine phantom. The following
schematics in Figures 2.5 and 2.6 show the size of the films utilized and the locations of
registration markings:
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Figure 2.5: Schematic of the axial film slice. All measurements are in millimeters. The
crosses denote the position of the registration pin locations.
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Figure 2.6: Schematic of the sagittal film slice. All measurements are in millimeters. The
crosses denote the position of the registration pin locations.
2.2

Qualitative Assessment of the Planning Utility of the Spine Phantom
The spine phantom will serve the purpose of assessing an institution’s ability to

image, develop a treatment plan, and deliver the stereotactic plan. An important component
of the utility of the phantom in this assessment is that it presents a reasonable simulation of
spinal anatomy. Granted, there is no one ‘correct’ anatomy for a spine and spine tumor;
spinal tumors vary greatly in size and presentation. Tumors may involve multiple levels,
range greatly in mass, and proximity to the spine. However, it is still critical that the design
of the spine phantom be representative in a few categories: depth, size, and proximity to the
spinal cord.
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To assess how well the spine phantom conforms to these criteria, CT scans for a
patient with comparable chest breadth to the spine phantom were acquired, and
measurements were taken of pertinent critical anatomy. This process allowed for a
reasonable qualitative assessment of the anatomic utility of the spine phantom.

2.3

Phantom Simulation and Treatment Planning

2.3.1 Simulation
The phantom was simulated on a Philips AcQsim CT scanner. Prior to scanning, film
and TLD were loaded into the phantom. The phantom was filled with water, with care taken
to avoid air bubbles (the design of the phantom, with a sloping chest, prevented air bubbles
from being near the treatment fields). The following parameters were used in the acquisition:
120 kVp, dynamic mAs, and 1.5 mm slice thickness. The simulation system allowed for
landmarking of the target isocenter during the simulation. Once landmarked, the CT couch
then shifted the room lasers for external marking of the simulation isocenter. Three plastic
fiducials were used to mark the laser positioning for an approximate treatment setup.

2.3.2 Treatment Planning System
The Philips “Pinnacle” treatment planning system (TPS), version 7.6, was utilized for
the design of each treatment plan administered to the spine phantom. This TPS utilized a set
of M.D. Anderson’s standard institutional beam data for the Varian 2100 linear accelerators.
These beam data are the clinical standard at M.D. Anderson. For IMRT planning, the TPS
employed an inverse planning algorithm; for a given beam arrangement and set of dose
parameters, the TPS calculated the optimal step-and-shoot MLC fields and the monitor units
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for each field. The planning process involved the incremental optimization of a plan until it
is clinically acceptable.
Pinnacle 7.6 was also utilized for the forward-planning process of a set of simplebeam arrangements plans. In this planning process, the field shapes, beam arrangements, and
beam weighting were set by the user; the TPS then calculated the necessary monitor units to
irradiate the target volume to the prescription dose.
The planned dose was calculated with the collapsed-cone convolution algorithm
implemented in Pinnacle. This dose algorithm is the clinical standard at M.D. Anderson.
The algorithm addressed the heterogeneity in the phantom (it does not assume a uniform
density of water, but calculated dose based on the CT number of the scanned phantom).
Addressing heterogeneity is important in the spine phantom because, depending on the beam
arrangement, a significant portion of the beam passes through high density simulated bone
material and low density simulated lung material.

2.3.3 Forward Treatment Planning
Four different treatment plans were developed for the spine phantom. In each plan, a
prescription dose level of 8 Gy was utilized. This dose level is not at the prescription level
delineated in the RTOG 0631 protocol (which escalates the dose to 16 Gy). This lower dose
level was chosen to keep the prescription within the dosimetric range of the radiochromic
film.
First, a four beam plan was created; beams were placed anteriorly, posteriorly, left,
and right (IEC convention: 0°, 180°, 270°, and 90°). The planning target volume (PTV) was
the acrylic tumor contour expanded by 1 mm. A dose of 8 Gy was prescribed to 95% of the
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PTV with equal beam weighting. This plan will be referred to herein as the four-field box
plan.
Next, a conformal plan was developed. Seven beams were arranged posteriorly (90°,
120°, 150°, 180°, 210°, 240°, and 270°). The acrylic tumor contour was expanded 1 mm.
The plan was conformal; each beam was collimated with the multi-leaf collimator to the
planning target volume. 8 Gy was prescribed to 95% of the PTV. This plan will be referred
to herein as the conformal plan.
The four-field box and conformal plans had no intensity modulation. These plans
were developed to help establish the baseline agreement between planned and measured
dose. Venselaar et al. demonstrated that, for simple beam geometries with larger field sizes,
the accuracy of the treatment planning calculation was greater (Venselaar 2001). These plans
had less clinical significance because they ignored spinal cord dose constraints in favor of
simplicity in design, ease of administration, and measurement accuracy.

2.3.4 Inverse Treatment Planning for IMRT
Next, two intensity modulated plans were developed. Two different beam
arrangements were utilized; one borrowed from the treatment plan for a patient at M.D.
Anderson, the other with a beam arrangement optimized for the irradiation of spinal
metastases (Pugachev 2001). The dose constraints for the anatomy of interest were taken
from the RTOG protocol 0631 (RTOG 2009). The pertinent constraints from the protocol
are listed in Table 2.1.
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Critical Structures and
Dose Constraints
Spinal Cord
Esophagus
Lungs

Critical Volume
10% / 3%
15%
20%

Max. Dose to Critical
Volume
3.5 Gy / 5 Gy
6 Gy
3.7 Gy

Max. Point Dose To
Critical Volume
7 Gy
8 Gy

Table 2.1: The critical structures and the dose/volume constraints for each delineated by the
RTOG protocol 0631.
In Philips’ Pinnacle treatment planning software, the dose constraints for the critical
structures were entered into the inverse treatment planning software. Each dose constraint
was assigned a weighting factor. In spinal radiosurgery, the spinal cord is the limiting factor
for higher levels of dose to the target volume, due to its proximity (in the spine phantom, the
spinal cord is 7 mm posterior to the target volume) and the devastating nature of radiation
induced myelopathy (Dodd 2008).
With the beams arranged and the dose constraints assigned, the TPS optimized the
modulated, step-and-shoot MLC fields for achieving the specified dose distribution. Once
the software created the plan, the dose distribution and dose-volume histograms were
assessed. Then, the weightings were adjusted, and the plan re-optimized. This iteration
continued until the resultant plan satisfied the user’s criteria (Holder 2004).
Two IMRT plans were developed, the dose distributions are shown in Figure 2.9 and
2.10. The first plan did not satisfy the clinical constraints; however, this plan still yielded
insight into how well the internal dose-measurement system agreed with the calculated dose
distribution. The second plan satisfied the clinical constraints set forth by the protocol. This
plan was the type of plan that may be administered by institutions participating in the
protocol.
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The first IMRT plan utilized 6 MV photons and seven fields; the beam angles were
100°, 120°, 150°, 180°, 200°, 230°, and 260°. This plan will be referred to herein as IMRT
plan #1.
The second IMRT plan also utilized 6 MV photons, but used nine fields; the beam
angles 60°, 105°, 130°, 150°, 165°, 180°, 210°, 230°, and 280°. This plan will be referred to
herein as IMRT plan #2.

2.4

The Treatment Plans
The following images in Figures 2.7-2.10 show the dose distributions on the axial CT

slices of the spine phantom at isocenter. The beam arrangement and number of monitor units
per field are listed below the dose distribution image. The prescription dose for each plan
was 8 Gy to at least 95% of the volume of the PTV.
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Four-Field Box:
Beam #
Gantry Angle:
MU’s:

1
0
343

2
270
343

3
180
343

4
90
343

Figure 2.7: The dose distribution for the four-field box plan; the gantry angles and numbers
of monitor units per field are shown. Below the table are the dose volume histograms for the
critical structures.

19

Conformal:
Beam #
Gantry Angle:
MU’s:

1
270
197

2
240
197

3
210
197

4
180
197

5
150
197

6
120
197

7
90
197

Figure 2.8: The dose distribution for the conformal plan; the gantry angles and number of
monitor units per field are shown. Below the table are the dose volume histograms for the
critical structures.
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IMRT #1:
Beam #:
Gantry Angle:
MU’s:

1
260
302

2
230
429

3
200
340

4
180
376

5
150
187

6
120
461

7
100
551

Figure 2.9: The dose distribution for the IMRT plan #1; the gantry angles and numbers of
monitor units per field are shown. Below the table are the dose volume histograms for the
critical structures.
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IMRT #2:
Beam #:
Gantry Angle:
MU’s

1
280
310

2
230
366

3
210
314

4
180
322

5
165
485

6
150
321

7
130
414

8
105
266

9
60
365

Figure 2.10: The dose distribution for the IMRT plan #2; the gantry angles and numbers of
monitor units per field are shown. Below the table are the dose volume histograms for the
critical structures.
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IMRT plan #2 met the constraints set forth by the RTOG 0631 protocol. The
cumulative dose-volume histogram of the spinal cord was compared to the average DVH
from a study conducted by Ryu et al. Figure 2.11 plots the DVH of IMRT plan #2 along
with the average spinal cord DVH for 50 patients from Ryu’s study. The comparison is
appropriate, as the partial cord volume was defined the same for Ryu’s patients and for
the IMRT plan #2 treatment.

Figure 2.11: A comparison of the partial cord DVH from the treatment plan utilized in
this study and the average DVH across 50 patients measured by Ryu et al.
The graph demonstrates that IMRT plan #2 achieved a dose-volume histogram for the
spinal cord that satisfies the requirements of the protocol, and has a lower cord dose at all
fractions of the partial cord volume when compared to clinical findings (Slotman 2006).
The DVH for the spinal cord may be significantly lower than that of the Ryu et al. study
because of the 7 mm gap between the spinal cord and the target volume (it is more than
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twice the minimal proximity in RTOG 0631, 3 mm, under which patients are excluded);
the spine phantom may represent a relatively easy planning challenge to institutions
participating in RTOG 0631.

2.5

Stereotactic Positioning
In radiosurgery, positioning must be accurate with a high level of confidence.

The RTOG protocol 0631 calls for 0-3 mm margins around the PTV. For these plans, the
margin used was 1 mm. Image guidance is a prerequisite for entry into RTOG Protocol
0631. Participating institutions approach radiosurgery with a variety of positioning
solutions. Typically, these involve the use of orthogonal kV imaging, followed by table
shifts and position checks. Other approaches include cone-beam CT or CT on rails. The
common theme is the utilization of imaging of anatomical structures at the time of
treatment (Chen 2009).
The rigidity of the phantom negated part of the positioning problem, as
positioning is not compromised once the phantom is in place. This rigidity obviates the
use of stabilization devices used in radiosurgery, such as the Elekta (Stockholm, Sweden)
BodyFIX® system.
For the irradiations conducted in this study, an alternate approach to image guided
positioning was devised to ensure accuracy. First, the location of the treatment isocenter,
noted from the TPS, was marked on a set of sagittal and axial radiochromic films. These
films were then loaded into the spinal insert, and the spinal insert was loaded into the
phantom. The phantom was set to an initial position according to external fiducials
placed during simulation on the patient support table. Then, a series of irradiations were
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administered with the collimator jaws set to a 1 mm gap. The gantry and collimator
angles were varied at 90° increments, creating a cross pattern on the radiochromic film.
The spinal insert was removed, and a shift was calculated between the machine isocenter
(the center of the cross pattern) and the treatment isocenter (marked on the film), and this
shift was applied to the patient support table. This process was iterated until there was
exact coincidence between the machine and treatment isocenters. An image of an
iteration of this process is shown in Figure 2.12.
This procedure is analogous to a hidden target test, described in AAPM TG-42.
In these types of tests, a lead or steel bearing is located at the treatment isocenter, and
deviations from the machine isocenter are measured (Schell 1995). In the localization
technique for the spine phantom described above, these deviations were measured, and
then corrected for with a patient support table shift.

Figure 2.12: Sample image of the radiochromic film used for localization of the
treatment isocenter to the machine isocenter. For the 1 mm wide fields, a 1.5 mm wide
region developed on the film. After each irradiation, the shift was calculated and applied;
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this process was iterated until the treatment isocenter coincided with the machine
isocenter.
This approach provided accurate positioning of the treatment isocenter to the
machine isocenter. Although institutions being credentialed cannot use this process for
positioning, the goal of this project was to assess the agreement of the planned dose
distribution to the measured dose distribution; error introduced by positioning uncertainty
from image guidance may have confounded the results. This localization procedure
bypassed the positioning uncertainty introduced by image guided positioning.

2.6

Treatment Administration
Once in position, the phantom was ready for treatment. The spinal insert was

loaded with film and TLD, and the MLC fields were loaded into the controller. After
checking the clearance of the linear accelerator around the spine phantom, the treatment
started. In order to bypass the record and verify system, the plans were delivered
manually. Since the treatment administration was manual, the gantry angle, collimator
angle, number of monitor units, and dynamic MLC file had to be loaded for each beam.
No safety interlocks prevented administration of the wrong field at the wrong angle, so a
double-tiered checklist was utilized to prevent error.
Each treatment plan was administered three times. Between each trial, the spine
insert was removed, and new TLD and film were placed in the insert. A long pin was
used to pierce the film for registration in the sagittal aspect. The phantom was not repositioned between trials.
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2.7

Data Collection and Processing
The RPC has a long history using TLD for dosimetry; it has been an essential

component of the remote quality assurance regimen for 30 years. Since 1996, TLDs have
been implemented in anthropomorphic phantoms. Kirby et al. described the uncertainties
in a powder TLD system, and ascribed a +/-5% action criterion for TLD checks,
corresponding to a 93% confidence interval (Kirby 1992).
TLD-100, manufactured by the Radiation Detection Company in Gilroy, CA, was
utilized in these experiments. The TLD powder is placed in custom made cylindrical
capsule measuring 15 mm in length and 4 mm in diameter. The wall thickness of the
capsule is 1 mm. Each capsule contained approximately 40 mg of TLD powder. The
TLD capsules utilized were ‘double loaded’; each capsule contained two discrete aliquots
(allowing for more measurement points). The volume of each of these aliquots is
approximately 13 mm3.

2.7.1 TLD Dose Calculation
The following formalism is utilized by the RPC for the calculation of dose from
the thermoluminescent response of the TLD (Davidson 2006).

D = TL * S * K l * K f * K e

D:

Absorbed dose to muscle

TL:

Mean thermoluminescent response per unit mass
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S:

Sensitivity or absorbed dose per thermoluminescent response for standards
irradiated with 60Co

Kl:

Linearity correction

Kf :

Fading correction

Ke:

Correction to energy used to irradiate (6 MV)

Determination of S:
The sensitivity, S, was determined during each TLD readout session, and corrects
for variations of the reflectivity of the planchette, optics, and electronics. First, TLD
known as ‘high dose standards,’ were irradiated in 60Co to approximately 20 Gy. Six
high dose standards were read, three at the beginning of the session, three at the end of
the session. The following equation was used to calculate S for the session:

S=

Ds
K l * K f ! Ts

Ds:

Expected dose to TLD (decay corrected ion chamber measurement)

T s:

mean thermoluminescent response for the high dose standards per unit
mass

Kl:

Linearity correction

Kf :

Fading correction

Determination of Kl:
The linearity correction, Kl, corrected the supra-linearity of the
thermoluminescent response (TL). For a batch of TLD (in this case, ‘B07’), capsules
were irradiated to ten dose levels, varying from 3-50 Gy. Three capsules were averaged
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at each dose level. This mean TL signal was then corrected for sensitivity and fading,
and normalized to the TL signal at the 3 Gy level. This normalized dose response was
then plotted against the relative signal. The inverse of this plot was calculated and fit
with a second order polynomial. This resultant relationship follows:

K l = aDl2 + bDl + c

a = 2.290E-08
b = -2.12E-04
c = 1.06
Dl = TL · S · Kf · Ke

Determination of Kf:
The TL response is dependent upon the time elapsed between the irradiation of
TLD and the readout. To correct for dependence, the fading of a batch B07 was
characterized with a double exponential:

Kf =

Ae

! Bd

N
+ Ce ! Dd

d =

number of days elapsed between irradiation and readout

N=

1.35

A=

1.28

B=

1.08E-4

C=

0.068
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D=

0.072

Determination of Ke:
The energy correction was calculated as the ratio of the response of TLD for 60Co
energy to the response of TLD at the energy of interest; for these trials, the energy
utilized was 6 MV. The correction applied for TLD irradiated at this energy was 1.03.
The TLD from each phantom irradiation trial were read by RPC staff members.
The results from the reading session include TL reading from controls and high dose
standards used to calculate the system sensitivity; dates and times for irradiations are also
included for fading corrections. These data were used in a TLD dose calculation
spreadsheet which iterated the solution to the previously described formalism to find the
absorbed dose to TLD.

2.7.2 Film Dosimetry
The radiochromic film measured the relative dose distributions. The optical
density of the film changes as a function of the dose received (due to a radiation induced
polymerization within the active layer of the film). The film was calibrated according to
RPC protocol. A piece of film from the batch being utilized for the irradiation trials was
cut into 3 cm by 3 cm squares. These calibration films were placed under 1.5 cm of solid
water with a further 9 cm of solid water as backscatter material. The calibration films
were then irradiated progressively from 50 monitor units to 1350 monitor units at a field
size of 35 cm by 35 cm. This process was repeated three times.
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The calibration films were scanned using the RPC’s film scanner, a CCD100
Microdensitometer manufactured by the Photoelectron Corporation (North Billerica,
MA). The scanned films were exported as 32 bit .FIT files.
The films were analyzed in ImageJ. ImageJ is open source image analysis
software developed by Wayne Rasband of the Research Services Branch of the NIH
(Bethesda, MD). At each irradiation level, the mean optical density of the calibration film
was measured. The mean optical density was averaged across the three trials at each
irradiation level. The MUs delivered were converted to dose at the film depth by
multiplying by the output factor at a 35 cm x 35 cm field size. The film was at Dmax for
the unit used, so no percent depth dose correction was needed.
OD vs. Dose
1
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0.7
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0.6
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16

Dose (Gy)

Figure 2.13: The dose response curve for the batch of Gafchromic EBT film utilized in
this study; the chart plots the optical density against the dose.
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The function to calculate the dose from a measured optical density was calculated
by inverting the data, and fitting a cubic function to the dose vs. OD curve, per RPC
protocol. The function calculated was as follows, with an R2 of .99:
Dose(OD) = 29.38 ! OD 3 " 14.96 ! OD 2 + 5.92 * OD

This dose response curve, shown in figure 2.13, was not used for absolute
dosimetry; rather, it was used to measure the relative dose distribution. The measured
distributions were corrected by the measured TLD dose.

2.7.3 Radiochromic Film Data Collection and Calibration to TLD
Using the CCD100 film scanner, the film results from each phantom irradiation
trial were converted into .FIT files, which contained a 512 by 512 array of the OD values.
These files were read into MATLAB and were converted to dose (cGy) using the cubic
fit from the dose response curve. These values were then converted to 16 bit .TIF image
files, with each pixel value in cGy. Thus, the minimal step was 1 cGy, and the typical
range recorded on the film was up to 1400 cGy.
The film was then corrected to the measured TLD dose. For each trial, there were
four TLD measurements: Anterior/Superior, Anterior/Inferior, Posterior/Superior, and
Posterior/Inferior. On the axial film, the mean doses at the two small circular localities
where the TLDs abut the film were measured. The ratio of the TLD dose to the film dose
was calculated (at each location). The average of these ratios was calculated. The film
response was then multiplied by this ratio. For the sagittal films, the same principle was
used, but the mean was taken of a rectangular region running the length of the TLDs.
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Figures 2.14 and 2.15 show the position of the TLDs relative to the calibration areas on
the film.
After the conversion to dose and the correction to the TLD dose measurement, the
film was registered to the planned dose distribution for gamma analysis.

Figure 2.14: An illustration of the calibration points of the film relative to the TLDs for
the axial plane.
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Figure 2.15: An illustration of the calibration points of the film relative to the TLDs for
the sagittal plane.
2.7.4 Exporting Dose Planes from the TPS
The ‘dose plane’ functionality within the Pinnacle TPS allows the user to sample
an arbitrary 2-D distribution from the dose volume. The physical film planes were
visible on the CT image in the planning interface of the Pinnacle software, which allowed
for an accurate selection of the correct plane for comparison. After calculation of the
dose distributions on a 2 x 2 x 2 mm3 dose grid, the dose was interpolated to 1 x 1 mm2
pixels. These planes were exported from Pinnacle, and reformatted into 16 bit .TIF
images, with each pixel value in cGy.

2.7.5 Processing and Registration of Measured Data
The pin pricks on the film provided the registration points to the planned dose.
The pin pricks were visible on the 16-bit TIF film images. However, the pin prick
locations had to be added to the 16-bit TIF planned dose distributions; this was
accomplished through an overlaying process. The planned dose distributions, in a given

34

plane, were collimated to a known size. The CT image was then collimated to the same
size. The CT image was overlaid onto the dose distribution, and the pin-prick locations
were ‘burned’ (by changing the dose value at those points) into the planned distribution.
This process was conducted for each planned dose distribution.
Both the planned and measured distributions then had registration marks.
However, there were differences in scaling and rotation between the images. To address
this, the coordinates of the pin pricks on the measured and planned distributions were
found in ImageJ. Then, image processing functionalities within MATLAB were used to
calculate a transformation matrix between these sets of points. The underlying distortion
between the images were rotation and scaling, so a ‘linear conformal’ transformation
matrix was calculated. For scaling the measured dose distribution, a bilinear
interpolation was utilized, per the procedure described by Childress et al. for conducting
gamma analyses (Childress 2005). Also, a smoothing median filter was applied to the
measured distribution to reduce noise, per RPC protocol (Davidson 2006). The
transformation matrix was applied to the measured dose distribution. The result is a
smoothed image scaled and rotated for an exact pinprick overlay to the planned
distribution; this process downsampled the measured distribution to meet the resolution
constraint of the planned dose distribution. This process, shown in Figure 2.16 was
conducted for each individual piece of film; one axial film per trial, and two sagittal films
per trial.
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(1)

(2)

(3)

(4)

Figure 2.16: Data processing: (1) Raw OD data for one of the axial films from an
irradiation trial. (2) OD data processed by the dose response curve and smoothed with a
median filter. (3) The resultant dose distribution downsampled with bilinear
interpolation and rotated to match the pin-prick locations of the planned distribution,
shown in (4), with the pin locations ‘burned’ onto the image.
2.9

Data Analysis: Gamma calculations, Isodose Planes and Profiles
Once the films were registered, the data were then read into DoseLab, publicly

available software for routine analysis of various dose distributions, created by Nathan
Childress (Childress 2005). The software was used for gamma calculations between
planned and measured distributions. Also, the software allowed for other qualitative
assessments of the distributions. Along with each of the gamma calculations, the
following assessments were included: isodose overlays, dose profiles, and point dose
comparisons. These types of assessments are utilized by the RPC for dose comparison in
a variety of IMRT phantom studies (Davidson 2006) (Molineu 2005). For the dose
profiles, the 5% dose difference and 3 mm DTA criteria were built onto the measured
film profiles by implementing the gamma calculation in one dimension in a Microsoft
Excel spreadsheet (Low 1998).
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2.9.1 Gamma Analysis
Gamma analysis has become a useful tool for routine IMRT quality assurance in
clinics. Gamma analysis takes into account both distance-to-agreement (DTA) and dose
difference in comparing planar dose distributions. Gamma analysis takes advantage of
the complementary sensitivities of DTA and dose difference, which are sensitive to low
and high dose gradients, respectively.
For two registered planar dose distributions, gamma analysis calculates the dose
difference and DTA for each pixel as components of a vector normalized to the criteria of
interest; if the magnitude of that vector exceeds 1, then that pixel fails the gamma
analysis at the defined criteria (Low 1998).
In Fig. 1, (rc, Dc) is a point on the calculated dose distribution (from treatment
planning software), and (rr, Dr) is a point on the reference dose distribution (measured
from the film plane). The symbols !d M and !DM are user defined tolerances for
distance-to-agreement and dose difference, respectively.
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Figure 2.17: Geometric relation of points used for a 2-D gamma calculation in assessing
the reference and calculated distributions. The x and y axes denote the spatial location
of dose, and D denotes the dose axis, and (rc, Dc) denotes and arbitrary calculated dose
value and location.

The ellipsoid is defined on the reference distribution by the selected tolerances for !d M
and !DM . The calculated distribution is queried for the minimum gamma
value, !r (rc , Dc ) :

#r (rc , Dc ) "

!r 2
!D 2
+
!d M2 !DM2

where !D and !r are defined as follows:
"D = Dc ! Dr
"r = rc ! rr
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The ! value for a point on the reference distribution is the smallest value of
!r (rc , Dc ) calculated. If the ! value is less than or equal to one, that point passes the

criteria (Low 1998). The percentage of passing points across a distribution is used as a
proxy for how well the planned and measured distributions accord.

2.9.2 Criteria Utilized
At what level should the tolerance for acceptable agreement between dose
distributions be defined? For daily IMRT quality assurance regimens, a variety of
tolerances are utilized in different clinics. For daily IMRT QA, M.D. Anderson utilizes a
5% dose difference and 3 mm distance to agreement; a dose distribution assessment fails
if less than 80% of the pixels pass the gamma analysis (Childress 2005). The RPC
utilized a range from 5% / 3mm to 7% / 7mm in assessing agreement of radiation therapy
fractions to its lung phantom. Davidson et al. found greater than 95% pixel passing rates
for the 5% / 3mm criteria when utilizing the collapsed-cone convolution dose algorithm
with heterogeneity correction (Davidson 2006). For intensity modulated stereotactic body
irradiations, UCLA conducts its quality assurance at a slightly tighter requirement, 3% /
3mm (Slotman 2006). The 3% / 3mm criteria were described as ‘quite stringent’ by the
authors, and that small areas of disagreement are expected in a gamma analysis.
In this project, the dose agreement criteria were the 5% / 3mm criteria utilized by
Davidson et al. The threshold for acceptable agreement used was a 95% pixel passing
rate across a given dose plane. An assessment at tightened dose difference and DTA
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criteria, 3% / 2mm, was conducted as well; these tighter criteria addressed the demand for
high geometric and dosimetric accuracy for a radiosurgical procedure.
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Chapter 3
3.1

Results and Discussion

Introduction
The following sections detail each of the parameters tested for each of the

irradiation plans: TLD measurements, dose profiles, isodose curves, and gamma analyses.
In each section, the results of each treatment plan are presented in this order: four-field
box, conformal, IMRT plan #1, and IMRT plan #2. The four-field box irradiation had a
simple geometry, and was used to establish a base line agreement for the non-modulated
irradiation. Next, the conformal irradiation was assessed; this plan had no modulation,
but had increased complexity in beam geometry. The four-field and conformal
irradiations were not clinically feasible plans. Next, IMRT plan #1 was assessed. IMRT
plan #1 did not meet the dose constraint requirements set forth by RTOG Protocol 0631.
Also, this plan was administered incorrectly (with an approximately 2.5 mm shift from
isocenter). These results are presented to demonstrate how a misadministration appears
in the analysis. According to Andrea Molineu, an RPC physicist, about 15% of
institutional failures in irradiating RPC phantoms are attributed to improper localizations,
so the data from the IMRT plan #1 could help establish how an improper localization
appears in the spine phantom. Finally, IMRT plan #2 was analyzed. IMRT #2 is an
optimized plan and satisfied the clinical guidelines set forth in RTOG Protocol 0631.

3.2

Qualitative Assessment of Anatomic Utility
There is no ‘perfect’ spinal tumor patient on which to base a phantom model;

these tumors present in a wide range of sizes and anatomical locations. Institutions have
utilized a variety of solutions for spine phantoms in spinal radiosurgery quality assurance.
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Yin et al. utilized a Rando® phantom (with simulated bone and lungs) loaded with
radiochromic film and an ion chamber for validation study of its spinal radiosurgery
treatments (Yin 2002). Medin et al. remapped treatment plans onto a CIRS thorax
phantom (with simulated lungs) for patient specific quality assurance (Medin 2006). The
spine phantom studied here was designed with the unique needs of the RPC in mind;
compromises were necessary to produce a phantom that is durable, water-filled,
anatomically simple and relatively inexpensive to produce. Thus, anatomical features
were approximated with geometric shapes. A few other considerations were made for the
spine phantom to be a representative spinal tumor case and a useful tool for the RPC:
location, depth, and size of the target volume.
Among 30 patients with spinal metastases treated by Dodd et al., the most
frequent disease site was the thoracic vertebral body, which is where the target volume
for the spine phantom is located (Dodd 2008).
Patients with spinal metastases at the University of Pittsburgh Medical Center
(Pittsburgh, PA) and Henry Ford Hospital (Detroit, MI) have their entire vertebral body
and pedicles of the involved site delineated as the target volume (Ryu 2009). In the spine
phantom, the design of the target volume shape approximated a vertebral body with
pedicles.
The depth and size of the target volume (the vertebral body and pedicles) in the
spine phantom should be close to that of a patient with a chest of similar breadth. CT
scans of a male M.D. Anderson patient were selected for comparison; this patient had a
chest breadth similar to that of the spine phantom A side-by-side comparison between
the spine phantom and this patient demonstrated similarities in the proportion of the
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phantom anatomy to that of the patient. The comparison relied primarily on an axial
view of the patient at the level of the heart, where the pedicles clearly define the spinal
canal.

Distance Comparison
Anatomy Measured:
Left to Right
Anterior to Posterior
Posterior to Anterior of Spinal Canal
Posterior to Anterior of Vertebral Body
Diameter Spinal Canal
Thickness of Vertebral Body (not shown)

Distance (cm)
Patient
38.2
29.1
6.8
9.7
2.0
3.4

Phantom
36.3
25
6.7
9.1
1.5
5.0

Figure 3.1: A comparison of important anatomical distances between a male patient and
the spine phantom.
The table in Figure 3.1 shows a close agreement for critical distances between the
patient and the spine phantom. The depth of the tumor, the size of the spinal canal, and
the size of the treatment area were similar in scale for the phantom and the patient. The
thickness of the target volume of the spine phantom was slightly more than that of the
vertebral body of the patient.
Another important aspect of the spine phantom is the relation of the tumor to the
spinal canal. RTOG 0631 does not allow patients to enter the protocol when a lesion is
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closer than 3 mm to the spinal cord (RTOG 2009). In the phantom, the shortest distance
between the spinal canal and the target volume was approximately 7 mm.
The target volume in the spine phantom was measured to be 41.5 cm3. After 500
cases at their institution, Gerszten et al. found an average tumor volume of 46 cm3, with a
range of volumes from 0.2 cm3 to 264 cm3. The tumor volume for the spine phantom is
near the average case, appropriate as a representative case (Gerszten 2007).

3.3

TLD Measurements
Tables 3.1-3.4 and figures 3.2-3.5 show the absolute dose measurements at each

of the TLD locations within the target volume. They were labeled as Anterior/Superior,
Anterior/Inferior, Posterior/Superior, Posterior/Inferior; the relative locations are shown
in Figure 2.4 in the Methods and Materials section. In each TLD capsule were two
separate aliquots of powder. Each of these aliquots contributed a single measurement.
Because of the close spatial proximity of these aliquots, they were grouped together.
Thus, over three irradiations, each TLD location had 6 samples. The planned dose to
each point was calculated by measuring the average dose to the TLD contour in the TPS.
The coefficient of variance was also calculated for each TLD location, so that the relative
spread could be compared between points.

3.3.1 Four-Field Box: TLD Results
Table 3.1 shows the TLD results from the four-field box irradiation.

4-Field Box
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TLD Position:
Superior/Anterior
Inferior/Anterior
Superior/Posterior
Inferior/Posterior

Mean Dose
(cGy)
900.8
904.0
921.4
909.6

Sample S.D.
7.3
6.6
9.7
13.0

COV (%)
0.8
0.7
1.1
1.4

Planned Dose
(cGy)
898.0
906.3
908.3
908.8

Planned/
Measured
0.997
1.003
0.990
0.999

Table 3.1: The absorbed dose to TLD at each position for the Four- Field Box
irradiation. The sample standard deviation and COV (%) was calculated at each point.
The ratio of planned/measured was calculated for each TLD position.
In order to show the agreement between the measured and planned dose for each
TLD location, Figure 3.1 shows the ratio of the planned to measured data with error bars
indicating the 95% confidence interval at each location (n = 6 measurements) for the
four-field box irradiation.

Box Irradiation: TLD Results
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Figure 3.2: The ratio of the planned to measured dose for the Four-Field Box
irradiation with 95% C.I.’s for n=6 measurements. Each gridline indicates a 1%
change, and the gridline at a ratio of 1 is in bold.
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Figure 3.1 demonstrates that the TLD measurements agree well with the planned dose.
The mean dose measured is slightly more than 1% off at the Superior/Posterior location.
At each location, the null hypothesis that Planned/Measured = 1 was tested at the 5%
confidence level. At each TLD location, the null hypothesis was not rejected.

3.3.2 Conformal Irradiation: TLD Results
Table 3.2 shows the TLD results from the conformal irradiation with the standard
deviation, COV (%), and the ratio of planned to measured dose.

Conformal
TLD Position:
Superior/Anterior
Inferior/Anterior
Superior/Posterior
Inferior/Posterior

Mean Dose
(cGy)
919.3
928.9
959.1
957.3

Sample S.D.
6.1
7.5
9.0
10.6

COV (%)
0.7
0.8
0.9
1.1

Planned Dose
(cGy)
920
927.2
960.1
961.8

Planned/
Measured
1.001
0.998
1.001
1.005

Table 3.2: The absorbed dose to TLD at each position for the Conformal irradiation.
The sample standard deviation and COV (%) was calculated at each point. The ratio of
planned/measured was calculated for each TLD position.

The following figure shows the ratio of planned to measured dose at each TLD
location for the conformal irradiation. The 95% C.I.’s are shown for each point.
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Conformal Irradiation: TLD Results
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Figure 3.3: The ratio of the planned to measured dose with 95% C.I.’s for n=6
measurements. Each gridline indicates a 1% change, and the gridline at a ratio of 1 is in
bold.
Figure 3.2 shows good agreement between the measured dose and the planned
dose for the conformal irradiation. At each location, the null hypothesis that
Planned/Measured = 1 was tested at the 5% confidence level. At each TLD location, the
null hypothesis was not rejected.

3.3.3 IMRT #1: TLD Results
The following table shows the TLD results from the conformal irradiation with
the standard deviation, COV, and the ratio of planned to measured dose.
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IMRT #1
TLD Position:
Superior/Anterior
Inferior/Anterior
Superior/Posterior
Inferior/Posterior

Mean Dose
(cGy)
830
807.2
795.7
787.1

Sample S.D.
10.5
4.7
8.0
17.2

COV (%)
1.3
0.6
1
2.1

Planned Dose
(cGy)
863
857.9
843.6
833.2

Planned/
Measured
1.040
1.063
1.060
1.059

Table 3.3: The absorbed dose to TLD at each position for each trial for the IMRT #1
irradiation. The sample standard deviation and COV (%) was calculated at each point.
The ratio of planned/measured was calculated for each TLD position.
The following figure shows the ratio of planned to measured dose at each TLD
location for the conformal irradiation. The 95% C.I.’s are shown for each point.

IMRT #1 Irradiation: TLD Results
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Figure 3.4: The ratio of the planned to measured dose with 95% C.I.’s for n=6
measurements. Each gridline indicates a 1% change, and the gridline at a ratio of 1 is in
bold.
Figure 3.3 shows poor agreement between the mean dose to TLD and the planned dose
for the IMRT plan #1 irradiation. However, this trial was misadministered (was
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incorrectly localized by approximately 2.5 mm), and a difference in the measured and
planned was expected, especially due to the large dose gradients within the target
volume. The incorrect positioning was more apparent in the isodose distribution of these
irradiations, shown in section 3.4.3. The method used to detect and measure the
misadministration is also discussed in section 3.4.3. At each location, the null hypothesis
that Planned/Measured = 1 was tested at the 5% confidence level. At each TLD location,
the null hypothesis was rejected.

3.3.4 IMRT #2: TLD Results
The following table shows the TLD results from the conformal irradiation with the
standard deviation, COV, and the ratio of planned to measured dose.
IMRT #2
TLD Position:
Superior/Anterior
Inferior/Anterior
Superior/Posterior
Inferior/Posterior

Mean Dose
(cGy)
1059.1
1050.7
1081
1095.6

Sample S.D.
14.0
20.0
33.2
27.4

COV (%)
1.3
1.9
3.1
2.5

Planned Dose
(cGy)
1054
1070
1083
1092

Planned/Measured
0.995
1.018
1.002
0.997

Table 3.4: The absorbed dose to TLD at each position for each trial for the IMRT #2
irradiation. The sample standard deviation and COV (%) was calculated at each point.
The ratio of planned/measured was calculated for each TLD position.
The following figure shows the ratio of planned to measured dose at each TLD location
for the conformal irradiation. The 95% C.I.’s are shown for each point.
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IMRT #2 Irradiation: TLD Results
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Figure 3.5: The ratio of the planned to measured dose with 95% C.I.’s for n=6
measurements. Each gridline indicates a 1% change, and the gridline at a ratio of 1 is
highlighted.
Figure 3.4 shows good agreement between the mean dose to TLD and the planned dose
for the IMRT plan #2 irradiation. However, at some locations, the 95% CI exceeded +/5%. At each location, the null hypothesis that Planned/Measured = 1 was tested at the
5% confidence level. At each TLD location, the null hypothesis was not rejected.
However, the 95% CI’s were larger for the IMRT #2 irradiation than for the four-field
box and conformal irradiations. This was likely due to the high dose gradients within the
target volume and across the TLD themselves.
The mean dose measurement at each TLD location for the four-field box,
conformal, and IMRT #2 plans were all within 2% of the planned dose. These results are
consistent with TLD results of the RPC study by Davidson et al. that utilized a Pinnacle
dose engine to predict dose in a lung phantom. In Davidson et al.’s study, the TLD dose
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measurements were within 2% of the predicted measurement in three trials (Davidson
2006). These results are also well within the 5% dose difference criteria applied in the
gamma analysis. These results demonstrated that, for a well-localized irradiation, the
Pinnacle collapsed-cone convolution superposition dose engine accurately predicted the
dose measured with TLD. One potential issue, however, is the steep dose gradients
across the TLD; the size of the 95% confidence intervals indicate that there is greater
uncertainty in intensity modulated irradiations such as IMRT plans #1 and #2 than in the
four-field box and conformal irradiations. The standard deviation of the dose to the TLD
contour, measured in the TPS, reveals a greater variation of dose across the TLD in the
intensity modulated plans. Whereas the coefficients of variance of the mean dose to the
TLD for the four field box and conformal plans are below 1%, the coefficients of
variance of the mean dose to the TLD for the IMRT plans #1 and #2 are between 2% and
3%. This observation agrees with the greater uncertainties seen in the measured TLD
doses of the intensity modulated plans.

3.4

Axial Profile and Isodose Distributions
Each sagittal and axial film plane was corrected to the TLD dose according to the

procedure described Section 2.8.3. The planned and measured dose distributions were
compared visually with isodose distributions and axial profiles. These comparisons
provided context for the gamma analyses. The isodose distributions allowed for
inspection of the agreement of selected dose contours across the entire film plane.
Although only one dimension is assessed with the dose profile, the 5% / 3 mm was
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displayed alongside. With the criteria displayed on the chart, the agreement of the
planned and measured dose profiles was assessed relative to the 5% / 3 mm criteria.
For each irradiation, the axial dose profile was taken through a registration
pinprick, as shown in Fig 3.6. For each measured dose profile, the three trials per
irradiation technique were averaged.

Figure 3.6: The axial dose profile location: for each irradiation technique, the dose
profiles were taken along the line indicated in the figure. The profiles were taken
through the pinprick in order to register each of the film series together. For each
irradiation technique, the 3 trials were averaged.

3.4.1 Four-Field Box Plan: Isodose Distributions and Axial Dose Profile
Figure 3.7 shows the isodose distributions in the axial and sagittal planes of the
first trial of the four-field box irradiation. The isodose distributions for the second and
third trials are in the appendix.
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Figure 3.7: Isodose distributions for the axial and sagittal planes of the Four-field Box
irradiation. The figure shows, from left to right, the axial, inferior sagittal, and superior
sagittal planes. Due to small deviations in the cropping and registration, the scale is not
the same for each portion of the figure.
Figure 3.7 visually demonstrates the close agreement of the selected isodose lines of the
planned and measured dose distributions for the first trial of the four-field box irradiation.
Because of some slight differences in registration of the superior and inferior portions of
the sagittal film, there is some overlap of the display.
Figure 3.8 shows the mean axial dose profile and the planned dose profile.
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Box Plan: Axial Dose Profile
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Figure 3.8: Axial dose profile: four-field box irradiation. The x-axis is the distance from
the top of the cropped axial plane. The film dose profile is the average of the three trials.
The 5% / 3 mm gamma criteria are represented as the dotted lines above and below the
film dose profile. The planned tumor volume and spinal cord are also shown on the
profiles.
Visual inspection of the graph of the planned to measured dose shows good agreement
along the profile; the planned dose did not move outside of the allowed tolerance along
the profile. However, the planned dose does deviate from the measured dose at the
posterior surface of the PTV, but not by more than 5%.
For the four-field box irradiation, the planned and measured dose distributions
agree across the film plane.
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3.4.2 Conformal Plan: Isodose Distributions and Axial Dose Profiles
Figure 3.9 shows the axial and sagittal isodose distributions for the first trial of
the conformal irradiation.

Figure 3.9: Isodose distributions for the axial and sagittal planes of the conformal
irradiation. The figure shows, from left to right, the axial, inferior sagittal, and superior
sagittal planes. Due to small deviations in the cropping and registration, the scale is not
the same for each portion of the figure.
Figure 3.9 visually demonstrates the close agreement of the planned and measured
dose distribution for the conformal irradiation. Small deviations of the planned dose
from the measured are perceptible across the sagittal and axial film planes, but overall,
there is a close agreement. Figure 3.10 is the axial dose profile for the conformal plan.
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Conformal Plan: Axial Dose Profile
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Figure 3.10: Axial dose profile: Conformal irradiation. The x-axis is the distance from
the top of the cropped axial plane. The film dose profile is the average of the three trials.
The 5% / 3 mm gamma criteria are represented as the dotted lines above and below the
film dose profile. The planned tumor volume and spinal cord are also shown on the
profiles.
In Figure 3.9, the axial dose profile demonstrates good agreement across the film plane.
The planned dose is very close to the mean film dose (n=3 trials), and does not approach
or exceed the 5% / 3 mm criteria bounding the measured dose.

3.4.3 IMRT #1 Plan: Isodose distributions and axial dose profile
Figure 3.11 shows the isodose distributions for the second trial of the IMRT #1
irradiation. The second trial is shown because the axial film of the first trial was over
exposed (the film may have been exposed to fluorescent light).

56

Figure 3.11: Isodose distributions for the axial and sagittal planes of the IMRT #1
irradiation. The figure shows, from left to right, the axial, inferior sagittal, and superior
sagittal planes. Due to small deviations in the cropping and registration, the scale is not
the same for each portion of the figure.
Figure 3.11 illustrates the result of the localization error during irradiation. The
planned and measured distributions have similar forms, but the measured distribution is
shifted relative to the planned distributions in 3 aspects: left, inferiorly, and posteriorly.
The shift is approximately 2.5 mm in magnitude. This shift magnitude was calculated
using the autocorrelation function in the DoseLab software; the software calculates a best
fit between the planned and measured dose distributions, and the spatial shift from the
pinprick registration to the calculated registration was measured. This error was
expected, as the phantom was localized using external markers placed during simulation.
Despite the localization error, the IMRT plan #1 data set was included to showcase how
the error can be visualized using these modes of data presentation.
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Figure 3.12 is the axial dose profile for the IMRT #1 irradiation.

IMRT #1 Dose Profiles
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Figure 3.12: Axial dose profile: IMRT #1 irradiation. The x-axis is the distance from
the top of the cropped axial plane. The film dose profile is the average of the two trials.
The 5% / 3 mm gamma criteria are represented as the dotted lines above and below the
film dose profile. The planned tumor volume and spinal cord are also shown on the
profiles.
Again, the shift in the measured distribution relative to the planned distribution is
apparent; while the profiles maintain the same form, the planned distribution nearly
exceeds the dose difference and distance-to-agreement criteria along the profile, due to
the localization error.
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3.4.4 IMRT #2 Plan: Isodose distributions and axial dose profile
Figure 3.13 is the isodose distributions for the first trial of the IMRT plan #2
irradiation. The isodose distributions for the other trials are in the Appendix.

Figure 3.13: Isodose distributions for the axial and sagittal planes of the IMRT #2
irradiation. The figure shows, from left to right, the axial, inferior sagittal, and superior
sagittal planes. Due to small deviations in the cropping and registration, the scale is not
the same for each portion of the figure.
The isodose distributions for this trial demonstrate agreement between the planned and
measured dose distributions. In the axial plane, the region of highest dose displayed
(1000 cGy) is slightly smaller than the planned region. When scanning vertically down
the sagittal and axial planes, the planned and measured isodose lines accord well along
the steep dose gradient. The accordance along the steep dose gradient is demonstrated
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with the axial dose profile, shown in Figure 3.14.
IMRT #2: Axial Dose Profile
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Figure 3.14: Axial dose profile: IMRT #2 irradiation. The x-axis is the distance from
the top of the cropped axial plane. The film dose profile is the average of the three trials.
The 5% / 3 mm gamma criteria are represented as the dotted lines above and below the
film dose profile. The planned tumor volume and spinal cord are also shown on the
profiles.
In Figure 3.14 the measured dose agrees well with the planned dose. The planned
dose does not deviate much from the measured dose, and along the entire profile does not
approach the bounding criteria. However, above 1000 cGy, the measured dose is slightly
lower than the planned dose. This discrepancy is also apparent in the isodose
distributions at 1000 cGy. These discrepancies may be attributable to the dose level
selected for the prescriptions. The maximum dose in the PTV from IMRT plan #2 is
significantly higher than the prescription dose of 800 cGy. Further scaling down the

60

prescription dose could allow for the film to capture the higher dose levels in a more
useful portion of the dynamic range of the film where there is a greater change in the
optical density per change in the dose.

3.5

Gamma Analysis
The gamma analyses were performed for the sagittal and axial film planes to test

the accordance of the planned and measured distributions. The gamma analysis process
is described in the Methods and Materials section; this project used the implementation in
the publicly available DoseLab software. For each ‘gamma map’ presented in this paper,
pixels on the gamma map passing the 5% / 3 mm criteria (gamma value less than 1) are
shown in grayscale, while pixels with a value greater than or equal to 1 are color mapped
from yellow to red, to clearly indicate where the gamma maps begins to fail to meet the
criteria (Note: gamma values of 1 are considered passing, but are color mapped to
enhance visualization of regions of failure). The axial and sagittal gamma maps for one
trial of each irradiation are presented here (corresponding to the isodose distributions
presented previously); the gamma maps for the remaining trials are in the Appendix. The
following figures are the gamma maps for single trials for the four-field box, conformal,
IMRT plan #1, and IMRT plan #2 irradiations.
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Figure 3.15: Gamma analysis maps of the axial and sagittal planes for the first trial of
the Four-field Box irradiation. The x and y axes are the pixel locations. The gamma value
at each point is color coded according to the bar on the right of the figure. Due to small
deviations in the image cropping and registration, the scale is not exactly the same for
each portion of the figure.
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Figure 3.16: Gamma analysis maps of the axial and sagittal planes for the first trial of
the conformal irradiation. The x and y axes are the pixel locations. The gamma value at
each point is color coded according to the bar on the right of the figure. Due to small
deviations in the image cropping and registration, the scale is not exactly the same for
each portion of the figure.
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Figure 3.17: Gamma analysis maps of the axial and sagittal planes for the second trial of
the IMRT #1 irradiation. The x and y axes are the pixel locations. The gamma value at
each point is color coded according to the bar on the right of the figure. Due to small
deviations in the image cropping and registration, the scale is not exactly the same for
each portion of the figure.
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Figure 3.18: Gamma analysis maps of the axial and sagittal planes for the first trial of
the IMRT #2 irradiation. The x and y axes are the pixel locations. The gamma value at
each point is color coded according to the bar on the right of the figure. Due to small
deviations in the image cropping and registration, the scale is not exactly the same for
each portion of the figure.
Figures 3.15 – 3.18 are the gamma maps for single trials for the four-field box,
conformal, IMRT #1, and IMRT #2 plans at the gamma criteria of 5% / 3 mm. The only
failure patterns of note occurred on the IMRT plan #1 irradiation, when the irradiation
was not well localized. On the IMRT plan #2 gamma maps, there were small regions of
failure near the center of the high dose region on the axial plane; these regions were also
apparent in the isodose distributions and axial dose profiles.
The following table shows the percentage of pixels, in each plane, that pass the
criteria for each irradiation. Also included are the percentages of passing pixels at
tighter gamma criteria. The tighter criteria are included because of the near perfect
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agreement at the 5% / 3mm level for the four-field box, conformal, and IMRT plan #2
irradiations.
Mean Percentage of Passing Pixels
Plan:
Plane:
5%/3mm
Box
Axial
99.6
Sagittal
99.3
3-D Conformal
Axial
99.4
Sagittal
99.8
IMRT #1
Axial
93.3
Sagittal
91.4
IMRT #2
Axial
99.6
Sagittal
100

5%/2mm
99.5
99.3
99.3
99.8
80.2
74.1
98.7
99.9

3%/2mm
95.6
95.4
97.9
97.1
63.3
61.3
94.4
98.5

Sample Size
3
3
3
3
2
3
3
3

Table 3.5: The mean percentage of pixels passing the gamma criteria for each dose plane
in each irradiation. Increasingly tighter criteria are shown in the table. Only 2 samples
were available for the axial plane of the IMRT plan #1 due to an overexposure of one
film to fluorescent light.
The threshold for good agreement across a dose plane is customarily that 95% of the
pixels pass the selected criteria. The table indicates that for the three well localized plans
(excluding IMRT plan #1, which was not well localized), there is nearly perfect
agreement at the 5% / 3 mm level. The irradiation with a 2.5 mm shift, IMRT plan #1,
shows slightly worse agreement, but is still above 90% agreement across the trials. When
subjected to a distance criterion tighter than the positioning error (the positioning error
was approximately 2.5 mm), the pixel passing percentage dropped precipitously, while
the other trials maintained near perfect agreement. This finding suggests that the RPC
may utilize a tighter distance to agreement criterion to better capture small positioning
errors committed by institutions irradiating the spine phantom.
The results of the gamma analysis were consistent with a previous RPC study by
Davidson et al., which found greater than 95% agreement across the gamma analysis
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maps when using the Pinnacle dose engine to predict doses in a lung phantom (Davidson
2006).

Chapter 4
4.1

Conclusions and Future Work

Conclusions
The spine phantom is to be used to test institution’s ability to scan, plan, and

administer a stereotactic radiosurgical treatment. The dosimetric utility of the spine
phantom was tested using a variety of irradiation plans, from unmodulated beams to
clinically applicable IMRT plans. This project assessed the dosimetric agreement
between the clinically utilized TPS at M.D. Anderson and the TLD/radiochromic film
system implemented in the phantom.
The anatomy of the spine phantom was determined to closely emulate that of a
patient with a similar chest breadth. The depth and size of the target volume and spinal
canal were very similar to that of the sample patient, and the proximity of the spinal canal
to the target volume did not exclude the spine phantom from RTOG 0631.
Using established 2-D dose plane comparison techniques, the planned and
measured dose distributions showed excellent agreement in the four-field box, conformal,
and IMRT plan #2 irradiations. The IMRT plan #1 irradiation did not pass the criteria set
forth in this project, due to poor localization of the treatment isocenter during the
treatment administration. This irradiation was included for illustrative purposes of the
failure patterns for a poor localization.
The isodose distributions and axial dose profiles were first utilized to assess the
agreement between the planned and administered dose across the axial and sagittal film
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planes. For the four-field box, conformal, and IMRT plan #2 irradiations, the isodose
distributions demonstrated agreement across the sagittal and axial film planes. For the
IMRT #2 distributions, there was some disagreement at the high dose levels. This
disagreement may warrant a revisiting of the film calibration at those higher dose levels,
over 1000 cGy.
The results of the isodose distributions and dose profiles were consistent with
studies conducted by the RPC for other anthropomorphic phantoms. Specifically, the
collapsed-cone convolution dose calculation algorithm accurately calculated the
measured dose across inhomogeneities. This project demonstrated that this assumption
can be extended to the new spine phantom when irradiating with intensity modulated
radiosurgical plans with small margins.
The gamma distributions for the four-field box, conformal, and IMRT plan #2
irradiations showed excellent agreement (> 95%) in the gamma analyses at the 5% / 3
mm and 3% / 2 mm levels. The IMRT #1 irradiation showed lower levels of agreement
at both criteria; this was expected, as the spine phantom was shifted 2.5 mm from the
planned isocenter. The following chart summarizes the levels of agreement for the
gamma maps for each irradiation:
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Figure 4.1: The mean percentage of pixels passing the gamma criteria for each
anatomic plane for each irradiation type.
This figure demonstrates the greater than 95% agreement across each gamma map for the
four field box, conformal and IMRT plan #2 irradiations at the 5% / 3 mm level. The
tighter criteria also reflect excellent agreement for these irradiations. Visual inspection of
the gamma maps and isodose distributions of the IMRT plan #1 irradiation reveal a clear
shift; however, the number of pixels passing criteria is greater than 90% at the 5% / 3mm
level. This reflects the relative laxity of that criterion; the 3% / 2mm criteria better
capture the misadministration. Thus, when selecting criteria, it is important to consider
the types and levels of errors tolerated, especially when considering the accuracy
necessary for spinal radiosurgery. The limiting accuracy of the localization process used
in this study should also be considered. The accuracy of the jaw positioning, per the
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AAPM Task Group 142 report, is +/- 1 mm for each jaw (Klein 2009). As both jaws are
subject to this uncertainty, the localization uncertainty of the process used here is at least
1 mm.
This project demonstrated the dosimetric utility of the spine phantom for
unmodulated and IMRT treatment plans for radiosurgical dose levels with proper
localization. This project confirmed that the phantom is useful for assessing institutions
participating in spinal radiosurgery protocols. The hypothesis, that the newly constructed
spine phantom provided a useful model for planning intensity modulated radiosurgery for
spinal tumors, and the collapsed-cone convolution dose algorithm accurately models the
dose distributions measured via radiochromic film and TLD, was not rejected through
testing in each specific aim of this research.

4.2

Future Work
This project applied to institutions that utilize conventional linear accelerators

equipped with MLCs and planning systems that utilize a collapsed-cone convolution dose
algorithm with heterogeneity correction, such as that implemented in the Pinnacle TPS.
However, another technology used for external beam radiosurgery is the Cyberknife
system, manufactured by Accuray (Sunnyvale, CA). Cyberknife utilizes a linear
accelerator mounted on an articulating robotic arm with circular apertures. Cyberknife
uses implanted gold fiducials and orthogonal kV imaging for localization. Accuray has
recently upgraded its treatment planning software, MultiPlan®, from a pencil beam based
calculation to a Monte Carlo dose algorithm (Mardirossian 2009). The RPC has already
adapted a spine phantom for use with Cyberknife by placing gold fiducials into the spinal
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insert. Future work may include generating plans in both versions of the Cyberknife
treatment planning software, irradiating the spine phantom on a Cyberknife system, and
using the criteria in this project to verify the dosimetric utility of the phantom for the
Cyberknife system.
The RPC is also implementing optically stimulated luminescent (OSL) dosimeters
in the place of TLD for remote dosimetry. The RPC’s transition to OSL is ongoing, and
the spinal insert could be adapted to Landauer’s (Glenwood, IL) NanoDot® OSL
cartridges.
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Figure 5.1: Isodose distributions for the axial and sagittal planes of the Four-Field Box
irradiation, Trial 2. The figure shows, from left to right, the axial, inferior sagittal, and
superior sagittal planes. Due to small deviations in the cropping and registration, the scale
is not the same for each portion of the figure.
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Figure 5.2: Gamma analysis maps of the axial and sagittal planes for the Four-Field Box
irradiation, Trial 2. The x and y axes are the pixel locations. The gamma value at each point
is color coded according to the bar on the right of the figure.
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Figure 5.3: Isodose distributions for the axial and sagittal planes of the Four-Field Box
irradiation, Trial 3. The figure shows, from left to right, the axial, inferior sagittal, and
superior sagittal planes. Due to small deviations in the cropping and registration, the scale
is not the same for each portion of the figure.
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Figure 5.4: Gamma analysis maps of the axial and sagittal planes for the Four-Field Box
irradiation, Trial 3. The x and y axes are the pixel locations. The gamma value at each point
is color coded according to the bar on the right of the figure.
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Figure 5.5: Isodose distributions for the axial and sagittal planes of the conformal
irradiation, Trial 2. The figure shows, from left to right, the axial, inferior sagittal, and
superior sagittal planes. Due to small deviations in the cropping and registration, the scale
is not the same for each portion of the figure.
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Figure 5.6: Gamma analysis maps of the axial and sagittal planes for the Conformal
irradiation, Trial 2. The x and y axes are the pixel locations. The gamma value at each point
is color coded according to the bar on the right of the figure.
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Figure 5.7: Isodose distributions for the axial and sagittal planes of the Conformal
irradiation, Trial 3. The figure shows, from left to right, the axial, inferior sagittal, and
superior sagittal planes. Due to small deviations in the cropping and registration, the scale
is not the same for each portion of the figure.
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Figure 5.8: Gamma analysis maps of the axial and sagittal planes for the Conformal
irradiation, Trial 3. The x and y axes are the pixel locations. The gamma value at each point
is color coded according to the bar on the right of the figure.
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Figure 5.9: Isodose distribution of the sagittal plane of the IMRT #1 irradiation, Trial 1. The
figure shows, from left to right, the inferior sagittal and superior sagittal planes. Due to
small deviations in the cropping and registration, the scale is not the same for each portion
of the figure.
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Figure 5.10: Gamma analysis map of the sagittal plane of the IMRT #1 irradiation, Trial 1.
The x and y axes are the pixel locations. The gamma value at each point is color coded
according to the bar on the right of the figure.
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Figure 5.11: Isodose distributions for the axial and sagittal planes of the IMRT #1
irradiation, Trial 3. The figure shows, from left to right, the axial, inferior sagittal, and
superior sagittal planes. Due to small deviations in the cropping and registration, the scale
is not the same for each portion of the figure.
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Figure 5.12: Gamma analysis maps of the axial and sagittal planes for the IMRT #1
irradiation, Trial 3. The x and y axes are the pixel locations. The gamma value at each point
is color coded according to the bar on the right of the figure.
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Figure 5.13: Isodose distributions for the axial and sagittal planes of the IMRT #2
irradiation, Trial 2. The figure shows, from left to right, the axial, inferior sagittal, and
superior sagittal planes. Due to small deviations in the cropping and registration, the scale
is not the same for each portion of the figure.
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Figure 5.14: Gamma analysis maps of the axial and sagittal planes for the IMRT #2
irradiation, Trial 2. The x and y axes are the pixel locations. The gamma value at each point
is color coded according to the bar on the right of the figure
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Figure 5.15: Isodose distributions for the axial and sagittal planes of the IMRT #2
irradiation, Trial 3.. The figure shows, from left to right, the axial, inferior sagittal, and
superior sagittal planes. Due to small deviations in the cropping and registration, the scale
is not the same for each portion of the figure.
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Figure 5.16: Gamma analysis maps of the axial and sagittal planes for the IMRT #2
irradiation, Trial 3. The x and y axes are the pixel locations. The gamma value at each point
is color coded according to the bar on the right of the figure.
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